Literature DB >> 31267277

Symptom response analysis of a randomized controlled trial of reflexology for symptom management among women with advanced breast cancer.

Alla Sikorskii1,2, Pratim Guha Niyogi2, David Victorson3, Deimante Tamkus4, Gwen Wyatt5.   

Abstract

PURPOSE: To examine symptom responses resulting from a home-based reflexology intervention delivered by a friend/family caregivers to women with advanced breast cancer undergoing chemotherapy, targeted, and/or hormonal therapy.
METHODS: Patient-caregiver dyads (N = 256) were randomized to 4 weekly reflexology sessions or attention control. Caregivers in the intervention group were trained by a reflexology practitioner in a 30-min protocol. During the 4 weeks, both groups completed telephone symptom assessments using the M. D. Anderson Symptom Inventory. Those who completed at least one weekly call were included in this secondary analysis (N = 209). Each symptom was categorized as mild, moderate, or severe using established interference-based cut-points. Symptom response meant an improvement by at least one category or remaining mild. Symptom responses were treated as multiple events within patients and analyzed using generalized estimating equations technique.
RESULTS: Reflexology was more successful than attention control in producing responses for pain (OR = 1.84, 95% CI (1.05, 3.23), p = 0.03), with no significant differences for other symptoms. In the reflexology group, greater probability of response across all symptoms was associated with lower number of comorbid condition and lower depressive symptomatology at baseline. Compared to odds of responses on pain (chosen as a referent symptom), greater odds of symptom response were found for disturbed sleep and difficulty remembering with older aged participants.
CONCLUSIONS: Home-based caregiver-delivered reflexology was helpful in decreasing patient-reported pain. Age, comorbid conditions, and depression are potentially important tailoring factors for future research and can be used to identify patients who may benefit from reflexology. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01582971.

Entities:  

Keywords:  Breast cancer; Reflexology; Symptom management; Symptom response

Mesh:

Year:  2019        PMID: 31267277      PMCID: PMC6939151          DOI: 10.1007/s00520-019-04959-y

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  32 in total

1.  Health-related information needs in a large and diverse sample of adult cancer survivors: implications for cancer care.

Authors:  Ellen Burke Beckjord; Neeraj K Arora; Wendy McLaughlin; Ingrid Oakley-Girvan; Ann S Hamilton; Bradford W Hesse
Journal:  J Cancer Surviv       Date:  2008-06-03       Impact factor: 4.442

2.  Methods for examining cancer symptom clusters over time.

Authors:  Canhua Xiao; Deborah Watkins Bruner; Bonnie Mowinski Jennings; Alexandra L Hanlon
Journal:  Res Nurs Health       Date:  2014-02       Impact factor: 2.228

3.  Latent Transition Analysis of the Symptom Experience of Cancer Patients Undergoing Chemotherapy.

Authors:  Sangchoon Jeon; Alla Sikorskii; Barbara A Given; Charles W Given; Nancy S Redeker
Journal:  Nurs Res       Date:  2019 Mar/Apr       Impact factor: 2.381

Review 4.  Cancer Symptom Cluster Management.

Authors:  Kristine L Kwekkeboom
Journal:  Semin Oncol Nurs       Date:  2016-10-24       Impact factor: 2.315

5.  Dyspnea experience and management strategies in patients with lung cancer.

Authors:  Ingela Henoch; Bengt Bergman; Ella Danielson
Journal:  Psychooncology       Date:  2008-07       Impact factor: 3.894

6.  Use of reflexology foot massage to reduce anxiety in hospitalized cancer patients in chemotherapy treatment: methodology and outcomes.

Authors:  R Quattrin; A Zanini; S Buchini; D Turello; M A Annunziata; C Vidotti; A Colombatti; S Brusaferro
Journal:  J Nurs Manag       Date:  2006-03       Impact factor: 3.325

7.  Effects of reflexotherapy on acute postoperative pain and anxiety among patients with digestive cancer.

Authors:  Shiow-Luan Tsay; Hsiao-Ling Chen; Su-Chiu Chen; Hung-Ru Lin; Kuan-Chia Lin
Journal:  Cancer Nurs       Date:  2008 Mar-Apr       Impact factor: 2.592

8.  Partner-delivered reflexology: effects on cancer pain and anxiety.

Authors:  Nancy L N Stephenson; Melvin Swanson; Joann Dalton; Frances J Keefe; Martha Engelke
Journal:  Oncol Nurs Forum       Date:  2007-01       Impact factor: 2.172

9.  Health-related quality-of-life outcomes: a reflexology trial with patients with advanced-stage breast cancer.

Authors:  Gwen Wyatt; Alla Sikorskii; Mohammad Hossein Rahbar; David Victorson; Mei You
Journal:  Oncol Nurs Forum       Date:  2012-11       Impact factor: 2.172

10.  Systemic corticosteroids for the management of cancer-related breathlessness (dyspnoea) in adults.

Authors:  Alison Haywood; Jacqueline Duc; Phillip Good; Sohil Khan; Kirsty Rickett; Petra Vayne-Bossert; Janet R Hardy
Journal:  Cochrane Database Syst Rev       Date:  2019-02-20
View more
  3 in total

1.  Effects of a patient-tailored integrative oncology intervention in the relief of pain in palliative and supportive cancer care.

Authors:  Eran Ben-Arye; Dana Elly; Noah Samuels; Orit Gressel; Katerina Shulman; Elad Schiff; Ofer Lavie; Amir Minerbi
Journal:  J Cancer Res Clin Oncol       Date:  2021-01-12       Impact factor: 4.553

2.  Reflexology and meditative practices for symptom management among people with cancer: Results from a sequential multiple assignment randomized trial.

Authors:  Gwen Wyatt; Rebecca Lehto; Pratim Guha-Niyogi; Sarah Brewer; David Victorson; Thaddeus Pace; Terry Badger; Alla Sikorskii
Journal:  Res Nurs Health       Date:  2021-07-19       Impact factor: 2.238

3.  Nursing support for symptoms in patients with cancer and caregiver burdens: a scoping review protocol.

Authors:  Jun Kako; Masamitsu Kobayashi; Yusuke Kanno; Kohei Kajiwara; Kimiko Nakano; Miharu Morikawa; Yoshinobu Matsuda; Yoichi Shimizu; Megumi Hori; Mariko Niino; Miho Suzuki; Taichi Shimazu
Journal:  BMJ Open       Date:  2022-09-14       Impact factor: 3.006

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.